Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 3, 2015, Pages 572-583

  Crevar, Corey J ^a   Carter, Donald M ^a   Lee, Kevin Y J ^a   Ross, Ted M ^a  

^a Vaccine and Gene Therapy Institute of Florida   (United States)

Author keywords

COBRA; H5N1; Influenza; Mice; Universal vaccine

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS LIKE PARTICLE VACCINE; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AVIAN INFLUENZA VIRUS; CLADISTICS; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; INFECTION PREVENTION; INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; VIRUS ISOLATION; VIRUS LIKE AGENT; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DRUG DESIGN; IMMUNOLOGY; INFLUENZA A VIRUS (H5N1); PROCEDURES; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; DRUG DESIGN; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MICE, INBRED BALB C; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84928677591     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1012013     Document Type: Article

References (43)

1. Webster RG, Govorkova EA. H5N1 influenza-continuing evolution and spread. N Engl J Med 2006; 355 (21):2174-7; PMID:17124014; http://dx.doi.org/10.1056/NEJMp068205.
2. Wibawa H, Henning J, Wong F, Selleck P, Junaidi A, Bingham J, Daniels P, Meers J. A molecular and antigenic survey of H5N1 highly pathogenic avian influenza virus isolates from smallholder duck farms in Central Java, Indonesia during 2007-2008. Virol J 2011; 8:425; PMID:21896207; http://dx.doi.org/10.1186/1743-422X-8-425.
3. Nguyen DC, Uyeki TM, Jadhao S, Maines T, Shaw M, Matsuoka Y, Smith C, Rowe T, Lu X, Hall H, et al. Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol 2005; 79(7):4201-12; PMID:15767421; http://dx.doi.org/10.1128/JVI.79.7.4201-4212.2005.
4. Wallace RG, Hodac H, Lathrop RH, Fitch WM. A statistical phylogeography of influenza A H5N1. Proc Natl Acad Sci U S A 2007; 104(11):4473-8; PMID:17360548; http://dx.doi.org/10.1073/pnas.0700435104.
5. Pabbaraju K, Tellier R, Wong S, Li Y, Bastien N, Tang JW, Drews SJ, Jang Y, Davis CT, Fonseca K, Tipples GA. Full-genome analysis of avian influenza A(H5N1) virus from a human, North America, 2013. Emerg Infect Dis 2014; 20(5):887-91; PMID:24755439.
6. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012; 336(6088):1534-41; PMID:22723413; http://dx.doi.org/10.1126/science.1213362.
7. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012; 486(7403):420-8; PMID:22722205.
8. Ducatez MF, Cai Z, Peiris M, Guan Y, Ye Z, Wan XF, Webby RJ. Extent of antigenic cross-reactivity among highly pathogenic H5N1 influenza viruses. J Clin Microbiol 2011; 49(10):3531-6; PMID:21832017; http://dx.doi.org/10.1128/JCM.01279-11.
9. Organization WH, Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as human vaccines. http://www.who.int/csr/disease/avian-influenza/guidelines/H5VaccineVirusUpdate20080214.pdf 2008.
10. Finnefrock AC, Liu X, Opalka DW, Shiver JW, Casimiro DR, Condra JH. HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responses. AIDS Res Hum Retroviruses 2007; 23(10):1283-92; PMID:17961117; http://dx.doi.org/10.1089/aid.2007.0098.
11. Giles BM, Ross TM. Development of a computationally optimized broadly reactive (COBRA) hemagglutinin for elicitation of protective antibodies against multiple clades of H5N1. Vaccine 2011; 29:3043-54; PMID:21320540; http://dx.doi.org/10.1016/j.vaccine.2011.01.100.
12. Giles BM, Ross TM. Computationally optimized antigens to overcome influenza viral diversity. Expert Rev Vaccines 2012; 11(3):267-9; PMID:22380818; http://dx.doi.org/10.1586/erv.12.3.
13. Kirchenbaum GA, Ross TM. Eliciting broadly protective antibody responses against influenza. Curr Opin Immunol 2014; 28C:1-76.
14. Giles BM, Bissel SJ, Dealmeida DR, Wiley CA, Ross TM. Antibody breadth and protective efficacy is increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin base H5N1 VLP vaccines. Clin Vacc Immunol 2012; 19(2):128-39; PMID:22190399; http://dx.doi.org/10.1128/CVI.05533-11.
15. Giles BM, Crevar CJ, Carter DM, Bissel SJ, Schultz- Cherry S, Wiley CA, Ross TM. Computationally-optimized hemagglutinin expressed on a virus-like particle vaccine elicits broadly-reactive antibodies that protect non-human primates from H5N1 clade 2 influenza infection. J Inf Dis 2012; 205(10):1562-70; http://dx.doi.org/10.1093/infdis/jis232.
16. Zhou F, Wang G, Buchy P, Cai Z, Chen H, Chen Z, Cheng G, Wan XF, Deubel V, Zhou P. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses. J Virol 2012; 86 (12):6970-8; PMID:22496212; http://dx.doi.org/10.1128/JVI.06930-11.
17. Haque ME, Giasuddin M, Chowdhury EH, Islam MR. Molecular evolution of H5N1 highly pathogenic avian influenza viruses in Bangladesh between 2007 and 2012. Avian Pathol 2014; 43(2):183-94; PMID:24689433; http://dx.doi.org/10.1080/03079457.2014.898244.
18. Osmani MG, Ward MP, Giasuddin M, Islam MR, Kalam A. The spread of highly pathogenic avian influenza (subtype H5N1) clades in Bangladesh 2010 and 2011. Prev Vet Med 2014; 114(1): 21-7; PMID:24485276; http://dx.doi.org/10.1016/j.prevetmed.2014.01.010.
19. Parvin R, Heenemann K, Halami MY, Chowdhury EH, Islam MR, Vahlenkamp TW. Full-genome analysis of avian influenza virus H9N2 from Bangladesh reveals internal gene reassortments with two distinct highly pathogenic avian influenza viruses. Arch Virol 2014; 159(7):1651-61; PMID:24420161.
20. Monne I, Fusaro A, Nelson MI, Bonfanti L, Mulatti P, Hughes J, Murcia PR, Schivo A, Valastro V, Moreno A, et al. Emergence of a highly pathogenic avian influenza virus from a low-pathogenic progenitor. J Virol 2014; 88(8):4375-88; PMID:24501401; http://dx.doi.org/10.1128/JVI.03181-13.
21. Policy C. f.I.D.R.a., Influenza Update. http://www.cidrap.umn.edu 2014.
22. Feng Y, Mao H, Xu C, Jiang J, Chen Y, Yan J, Gao J, Li Z, Xia S, Lu Y. Origin and characteristics of internal genes affect infectivity of the novel avian-origin influenza A (H7N9) virus. PLoS One 2013; 8(11):e81136; PMID:24278391; http://dx.doi.org/10.1371/journal.pone.0081136.
23. Wu A, Su C, Wang D, Peng Y, Liu M, Hua S, Li T, Gao GF, Tang H, Chen J, et al. Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell Host Microbe 2013; 14(4):446-52; PMID:24055604; http://dx.doi.org/10.1016/j.chom.2013.09.001.
24. Lam TT, Wang J, Shen Y, Zhou B, Duan L, Cheung CL, Ma C, Lycett SJ, Leung CY, Chen X, et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 2013; 502 (7470):241-4; PMID:23965623; http://dx.doi.org/10.1038/nature12515.
25. Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, Bi Y, Wu Y, Li X, Yan J, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 2013; 381(9881):1926-32; PMID:23643111; http://dx.doi.org/10.1016/S0140-6736(13)60938-1.
26. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368(20):1888-97; PMID:23577628; http://dx.doi.org/10.1056/NEJMoa1304459.
27. Yang ZY, Wei CJ, Kong WP, Wu L, Xu L, Smith DF, Nabel GJ. Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 2007; 317(5839):825-8; PMID:17690300; http://dx.doi.org/10.1126/science.1135165.
28. Wang G, Zhou F, Buchy P, Zuo T, Hu H, Liu J, Song Y, Ding H, Tsai C, Chen Z, et al. DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin. J Infect Dis 2014; 209 (5):676-85; PMID:23911711; http://dx.doi.org/10.1093/infdis/jit414.
29. Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One 2008; 3(1):e1501; http://dx.doi.org/10.1371/journal.pone.0001501.
30. Giles BM, Bissel SJ, Dealmeida DR, Wiley CA, Ross TM. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. Clin Vaccine Immunol 2012; 19(2):128-39; PMID:22190399; http://dx.doi.org/10.1128/CVI.05533-11.
31. Talaat KR, Luke CJ, Khurana S, Manischewitz J, King LR, McMahon BA, Karron RA, Lewis KD, Qin J, Follmann DA. A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response. J Infect Dis 2014; 209 (12):1860-9; PMID:24604819; http://dx.doi.org/10.1093/infdis/jiu123.
32. Ross TM, Xu Y, Bright RA, Robinson HL. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol 2000; 1(2):127-31; PMID:11248804; http://dx.doi.org/10.1038/77802.
33. Soding J. Protein homology detection by HMMHMM comparison. Bioinformatics 2005; 21(7):951- 60; PMID:15531603; http://dx.doi.org/10.1093/bioinformatics/bti125.
34. Soding J, Biegert A, Lupas AN. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res 2005; 33(Web Server issue):244-8; PMID:15980461; http://dx.doi.org/10.1093/nar/gki408.
35. Giles BM, Ross TM. A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets. Vaccine 2011; 29(16):3043-54; PMID:21320540; http://dx.doi.org/10.1016/j.vaccine.2011.01.100.
36. Gillim-Ross L, Subbarao K. Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev 2006; 19(4):614-36; PMID:17041137; http://dx.doi.org/10.1128/CMR.00005-06.
37. Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov A. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005; 366(9492):1175-81; PMID:16198766; http://dx.doi.org/10.1016/S0140-6736(05)67338-2.
38. Bright RA, Ross TM, Subbarao K, Robinson HL, Katz JM. Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology 2003; 308(2):270-8; PMID:12706077; http://dx.doi.org/10.1016/S0042-6822(03)00008-4.
39. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006; 295(8):891-4; PMID:16456087; http://dx.doi.org/10.1001/jama.295.8.joc60020.
40. Mitchell JA, Green TD, Bright RA, Ross TM. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 2003; 21(9-10):902-14; PMID:12547601; http://dx.doi.org/10.1016/S0264-410X(02)00539-X.
41. Askonas B, McMichael A, Webster RG. The immune response to influenza viruses and the problem of protection against infection. in Basic and Applied Influenza Research, B. AS, Editor. 1982, CRC Press. p. 159- 88.
42. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, et al. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res 2008; 36(Web Server issue):W465-9; PMID:18424797; http://dx.doi.org/10.1093/nar/gkn180.
43. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D. The influenza virus resource at the National Center for Biotechnology Information. J Virol 2008; 82(2):596-601; PMID: 17942553; http://dx.doi.org/10.1128/JVI.02005-07.